Keel Point, LLC Abbott Laboratories Transaction History

Keel Point, LLC

$1.19 Billion
Q3 2024

A detailed history of Keel Point, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Keel Point, LLC holds 6,971 shares of ABT stock, worth $799,991. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,971

Previous 7,320 4.77%

Holding current value

$799,991

Previous $760,000 4.47%

% of portfolio

0.07%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $34,924 - $41,227	-349 Reduced 4.77%	6,971 $794,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $8,662 - $9,669	-86 Reduced 1.16%	7,320 $760,000
Q1 2024 Apr 16, 2024	BUY	$109.52 - $120.96 $67,354 - $74,390	615 Added 9.06%	7,406 $841,000
Q4 2023 Jan 30, 2024	BUY	$90.19 - $110.4 $62,411 - $76,396	692 Added 11.35%	6,791 $747,000
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $55,885 - $67,052	-585 Reduced 8.75%	6,099 $590,000
Q2 2023 Jul 12, 2023	BUY	$100.78 - $112.29 $35,172 - $39,189	349 Added 5.51%	6,684 $728,000
Q1 2023 Apr 03, 2023	BUY	$96.86 - $114.01 $168,245 - $198,035	1,737 Added 37.78%	6,335 $641,000
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $84,888 - $99,587	893 Added 24.1%	4,598 $0
Q3 2022 Oct 05, 2022	SELL	$96.76 - $112.03 $580 - $672	-6 Reduced 0.16%	3,705 $359,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $61,548 - $74,392	603 Added 19.4%	3,711 $409,000
Q1 2022 Apr 27, 2022	BUY	$114.02 - $139.04 $10,945 - $13,347	96 Added 3.19%	3,108 $368,000
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $26,456 - $32,394	229 Added 8.23%	3,012 $423,000
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $308,799 - $341,621	2,647 Added 1946.32%	2,783 $329,000
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $285,738 - $336,355	-2,701 Reduced 95.21%	136 $1.08 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $14,704 - $17,309	-139 Reduced 4.67%	2,837 $329,000
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $69,222 - $81,554	636 Added 27.18%	2,976 $357,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $2,100 - $2,288	20 Added 0.86%	2,340 $256,000
Q3 2020 Nov 18, 2020	BUY	$91.64 - $111.29 $212,604 - $258,192	2,320 New	2,320 $252,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $597,569 - $722,461	-9,024 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $52,331 - $59,166	-930 Reduced 9.34%	9,024 $541,000
Q4 2017 Feb 08, 2018	SELL	$53.68 - $57.47 $118,096 - $126,434	-2,200 Reduced 18.1%	9,954 $568,000
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $68,533 - $76,490	-1,426 Reduced 10.5%	12,154 $649,000
Q2 2017 Aug 15, 2017	BUY	N/A	13,580	13,580 $660,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.

Account